Shanghai Shyndec Pharmaceutical Co., Ltd. (600420) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Shyndec Pharmaceutical Co., Ltd.

Why is Shanghai Shyndec Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -2.62% and Operating profit at 1.93% over the last 5 years

Negative results in Dec 25

OPERATING CASH FLOW(Y) Lowest at CNY 1,166.16 MM
INVENTORY TURNOVER RATIO(HY) Lowest at 0 times
RAW MATERIAL COST(Y) Grown by 102.87% (YoY)

With ROE of 8.91%, it has a very attractive valuation with a 1.05 Price to Book Value

Over the past year, while the stock has generated a return of -3.22%, its profits have fallen by -8.9%
At the current price, the company has a high dividend yield of 2.8

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 22.49% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -3.22% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Shyndec Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shanghai Shyndec Pharmaceutical Co., Ltd.

-19.71%

-0.25

18.14%

China Shanghai Composite

21.43%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-7.58%

EBIT Growth (5y)

-6.95%

EBIT to Interest (avg)

20.12

Debt to EBITDA (avg)

0.27

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

0.72

Tax Ratio

20.96%

Dividend Payout Ratio

42.73%

Pledged Shares

Institutional Holding

ROCE (avg)

12.64%

ROE (avg)

10.07%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.86

EV to EBIT

11.57

EV to EBITDA

6.97

EV to Capital Employed

0.83

EV to Sales

1.08

PEG Ratio

Dividend Yield

5.62%

ROCE (Latest)

7.15%

ROE (Latest)

6.54%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

INVENTORY TURNOVER RATIO(HY)

Highest at 3.17 times

-23What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 1,082.2 MM

ROCE(HY)

Lowest at 5.23%

OPERATING PROFIT(Q)

Lowest at CNY 221.09 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 10.71 %

RAW MATERIAL COST(Y)

Grown by 14.27% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -17.39 %

NET SALES(Q)

At CNY 2,064.31 MM has Fallen at -11.57%

NET PROFIT(Q)

At CNY 138.4 MM has Fallen at -41.21%

Here's what is working for Shanghai Shyndec Pharmaceutical Co., Ltd.

Inventory Turnover Ratio

Highest at 3.17 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Shanghai Shyndec Pharmaceutical Co., Ltd.

Operating Cash Flow

Lowest at CNY 1,082.2 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit

Lowest at CNY 221.09 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 10.71 % and Fallen

In each period in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Sales

At CNY 2,064.31 MM has Fallen at -11.57%

over average net sales of the previous four periods of CNY 2,334.41 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Profit

At CNY 138.4 MM has Fallen at -41.21%

over average net sales of the previous four periods of CNY 235.4 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Debt-Equity Ratio

Highest at -17.39 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 14.27% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales